SBC Medical Group Holdings Incorporated logo

SBC Medical Group Holdings Incorporated(SBC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
SELL
SELL for 1 day
PROFIT SINCE LAST BUY
+41.26% ▲
LAST CLOSE
$5.17
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SBC

11/20/2026: SBC (1-star) is a SELL. SELL for 1 day. Simulated Profits (41.26%). Updated daily EoD!

SBC Medical Group Holdings Incorporated operates as a prominent medical services organization providing management and operational support to cosmetic and healthcare clinics primarily in Japan and abroad. The company exhibits robust operating margins, strong cash flow generation, and consistent network expansion across multiple aesthetic brands. Its primary growth strategy involves scaling international operations and diversifying into high-potential non-aesthetic fields like longevity medicine. Key risks include heavy reliance on discretionary consumer spending, localized geographic exposure, and intense competition within elective healthcare. Suited for growth-oriented investors, the stock warrants close monitoring of international execution, AI-driven efficiencies, and regulatory developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company delivers rapid top-line and earnings expansion driven by network scaling and international MSO opportunities.
Momentum investorStrong fit while signal remains positiveFavorable earnings reports and solid quarterly momentum can attract technical interest conditional on positive market sentiment.
Value investorMixed fitWhile operating profitability is high, valuation multiples fluctuate based on sentiment toward small-cap cross-border listings.
Dividend investorWeak fitThe company prioritizes capital reinvestment and business expansion over regular dividend payouts.
Low-risk investorWeak fitSmall-cap cross-border listing characteristics and exposure to discretionary consumer trends introduce notable volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighSmaller public float and micro-to-small cap status can lead to sharp short-term price fluctuations.
Valuation riskMediumValuations depend heavily on sustained high growth rates matching investor expectations.
Competition risk (aesthetic and medical MSO competition)Medium / highIntense market competition requires continuous innovation and service differentiation to protect margins.
Business qualityStrongThe franchise MSO model generates high operating and EBITDA margins with solid cash conversion.
Dividend incomeLow / noneNo regular dividend yield is offered as capital is retained for expansion.
Execution riskMediumSuccessful international expansion and entry into new medical verticals require flawless operational execution.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 530.32M USD
Price to earnings Ratio 10.14
1Y Target Price 10
Price to earnings Ratio 10.14
1Y Target Price 10
Volume (30-day avg) 312.6K shares
Beta 0.52
52 Weeks Range 2.78 - 7.39
Updated Date 11/21/2026
52 Weeks Range 2.78 - 7.39
Updated Date 11/21/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.51

Sector & Industry Intelligence

Sector

Industrials

Watchful
Sentiment
Weak Bearish
Momentum
BUY Breadth Improving
BUY participation
25.6%
Active BUY / eligible
20 / 78
30-Day BUY Count Change
+6
Market state
Weak Bearish / Bullish Reversal

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Consulting Services

BUY participation
0.0%
Active BUY / eligible
0 / 1
30-Day BUY Count Change
-1

Eligible universe: 1 stock.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit 5.07%
Avg. Invested days 47
Today’s Advisory SELL
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SBC receives a 4-star rating, supported by solid unit economics, solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
SBC has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and moderate ownership. In FY2025 versus FY2024, moderate earnings growth (+9.4%) and solid cash generation (FCF margin 12.8%) are partially offset by negative revenue growth (-15.5%).

Financial Health Rating

★★★★★
SBC's financial health is supported by solid profitability, including gross margin of 73.3% and operating margin of 38.9%. Overall financial-health metrics support a 4-star score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is SBC's strongest growth driver at +29.8% FY2025 versus FY2024 (solid, 4 stars). By comparison, while revenue growth (-15.5%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 5.4% (soft) and 17.6% of outstanding shares are publicly tradable (soft). Insider ownership of 81.53% supports management-shareholder alignment.

Top 5 Institutional Investors

Lumbard Investment Counseling LLC 1.68%
BlackRock Inc 0.90%
Geode Capital Management, LLC 0.42%
Citadel Advisors Llc 0.14%
Vanguard Capital Management, LLC 0.13%

Unit Economics (Per $1K Revenue)

★★★★★
SBC generates approximately $733 of gross profit, $389 of operating income, and $128 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong margins, cash conversion, and capital efficiency support the rating.

Economic Dimensions

★★★★★
Effective Tax Rate: 37.80%

Quantitative Style Profile

★★★★★
SBC has a high-quality, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedQuality TiltLow VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
MSO Management & Franchise ServicesFees charged to partner medical institutions for administrative support, IT systems, and trademark licensing.SBC acts as the backbone service provider for clinics, earning predictable management fees based on network performance.
Marketing & Advertising SolutionsDigital marketing campaigns and customer acquisition services tailored for aesthetic clinics.Helps clinics attract patients efficiently while capturing marketing-related revenue streams.
Medical Equipment & Consumables SupplyWholesale procurement and supply of specialized medical goods to partner clinics.Generates steady commercial revenue from essential supplies utilized daily across the clinic network.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-13
When Before Market
Estimate 0.11
Actual 0.15

Profitability

Profit Margin 27.26%
Operating Margin (TTM) 39.89%

Management Effectiveness

Return on Assets (TTM) 12.72%
Return on Equity (TTM) 19.29%

Valuation

Trailing PE 10.14
Forward PE 12.02
Enterprise Value 484.46M
Price to Sales(TTM) 2.79
Enterprise Value 484.46M
Price to Sales(TTM) 2.79
Enterprise Value to Revenue 2.53
Enterprise Value to EBITDA 5.52
Shares Outstanding 102.58M
Shares Floating 18.10M
Shares Outstanding 102.58M
Shares Floating 18.10M
Percent Insiders 81.53
Percent Institutions 5.41

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.